Figure 1 .
(A) Serum levels of nerve growth factor (NGF) (ng/ml) in patients with systemic sclerosis (SSc) and controls (C),*p<0.00001; (B) NGF levels (ng/ml) in limited (lSSc) and diffuse (dSSc) subsets of patients with SSc, *p<0.01; (C) NGF levels (ng/ml) in patients with SSc with joint involvement (JI) and without joint involvement (WJI), *p<0.00002.